Fear of new foods may affect more than dietary variety
View as a Web Page
News Medical
 
  Men's Health Men's Health logo  
  The latest men's health news from News Medical  
 Filtered coffee links to slower biological aging while instant coffee shows the oppositeFiltered coffee links to slower biological aging while instant coffee shows the opposite
 
Filtered coffee consumption was associated with slower biological aging, while instant coffee was linked to faster aging in UK Biobank participants. The cross-sectional findings do not prove causation, but they suggest that brewing method may influence coffee’s relationship with aging biomarkers.
 
 
 Fear of new foods may affect more than dietary varietyFear of new foods may affect more than dietary variety
 
Higher food neophobia was associated with poorer self-reported physical and mental health among 4,537 adults in Australia, the United Kingdom, and the United States. The relationship remained after accounting for age, gender, education, and country, although the cross-sectional study could not establish causation.
 
   GLP-1 receptor activation linked to lower depression and bipolar disorder oddsGLP-1 receptor activation linked to lower depression and bipolar disorder odds
 
Genetic analyses linked BMI-related GLP-1 receptor activation to better mental well-being and lower odds of major depressive disorder and bipolar disorder. The findings do not prove that GLP-1 receptor agonist drugs treat psychiatric conditions, and randomized clinical trials are still needed.
 
   Face recognition declines with age may lie in how your eyes moveFace recognition declines with age may lie in how your eyes move
 
Aging-related declines in face recognition are linked to reduced eye movement consistency, emphasizing the role of cognitive processes in visual routines.
 
   New ctDNA blood test improves personalized prostate cancer treatmentNew ctDNA blood test improves personalized prostate cancer treatment
 
A noninvasive DNA blood test can identify metastatic castration-resistant prostate cancer (mCRPC) patients who are most likely to benefit from 223Ra radiopharmaceutical therapy and monitor their progress throughout treatment, according to new research published in the July issue of The Journal of Nuclear Medicine.
 
   Maternal diets high in UPFs may influence children’s health years laterMaternal diets high in UPFs may influence children’s health years later
 
A narrative review of 84 publications links higher ultra-processed food intake during pregnancy and early childhood with poorer diet quality, maternal complications, childhood obesity, and potential immune, metabolic, and neurodevelopmental effects. The authors identify possible microbiome and biopsychosocial pathways but emphasize that the predominantly observational evidence cannot establish causality.
 
 Breast and prostate cancer survival worsens with metabolic syndrome
 
Breast and prostate cancer survival worsens with metabolic syndromeA SEER-Medicare analysis of more than 200,000 adults aged 66 and older found that metabolic syndrome was associated with about twice the adjusted hazard of death from any cause after breast or prostate cancer. The condition was also linked to higher cancer-specific, cardiovascular-specific, and liver-failure-specific mortality, although the observational design prevents causal conclusions.
 
 
 Blood p-tau217 levels signal cognitive impairment risk years before symptoms emerge
 
Blood p-tau217 levels signal cognitive impairment risk years before symptoms emergeHigher baseline plasma p-tau217 was associated with greater 5- and 10-year risks of cognitive impairment and faster cognitive decline among 2,684 cognitively unimpaired adults. Very high levels corresponded to an estimated 38% risk at five years, but selected cohorts and limited long-term data mean routine screening and individualized prediction remain premature.
 
 
 New guideline offers recommendations for testosterone replacement therapy use
 
New guideline offers recommendations for testosterone replacement therapy useThe Society's Clinical Practice Guideline on testosterone replacement therapy in men with hypogonadism offers recommendations on appropriate testing and prescribing practices.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026